Hoda Derakhshanian1,2, Abolghassem Djazayery3, Mohammad Hassan Javanbakht4, Mohammad Reza Eshraghian5, Abbas Mirshafiey6, Mahnaz Zarei4, Ehsan Alvandi4, Ehsan Djalali7, Mahmoud Djalali4. 1. Department of Biochemistry, Genetics and Nutrition, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran. 2. Dietary Supplements and Probiotic Research Center, Alborz University of Medical Sciences, Karaj, Iran. 3. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran. 5. Department of Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 6. Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. 7. Department of Veterinary, Science and Research Branch of Islamic Azad University, Tehran, Iran.
Abstract
BACKGROUND: Diabetic nephropathy is one of the most important microvascular complications and a major cause of morbidity and mortality in diabetic patients. This study was designed to investigate the effect of vitamin D on the expression of three key genes involved in the development of diabetic nephropathy. METHODS: Twenty-four male Sprague-Dawley rats were randomly divided into three groups. The first group served as control and the other two groups received intraperitoneal injections of 45 mg/kg STZ to develop diabetes. The groups were treated for four weeks either with placebo or two vitamin D injections of 20,000 IU/kg. Serum glucose, insulin, and HbA1c levels, and AGE cellular receptor (RAGE), aldose reductase (AR) and glutamine: fructose-6-phosphate aminotransferase (GFAT) gene expression were assessed in kidney tissue at the end of the experiment. RESULTS: Vitamin D treatment resulted in a significant increase in insulin concentration, which could improve hyperglycaemia in diabetic rats. Serum HbA1c decreased slightly but insignificantly following the vitamin D injections. In addition, expression of GFAT, a key regulatory enzyme in the hexosamine pathway, was significantly reduced following vitamin D administration. CONCLUSION: Vitamin D may reduce diabetic nephropathy not only by improving blood glucose and insulin levels, but also by modulating hexosamine pathways in kidney.
BACKGROUND: Diabetic nephropathy is one of the most important microvascular complications and a major cause of morbidity and mortality in diabetic patients. This study was designed to investigate the effect of vitamin D on the expression of three key genes involved in the development of diabetic nephropathy. METHODS: Twenty-four male Sprague-Dawley rats were randomly divided into three groups. The first group served as control and the other two groups received intraperitoneal injections of 45 mg/kg STZ to develop diabetes. The groups were treated for four weeks either with placebo or two vitamin D injections of 20,000 IU/kg. Serum glucose, insulin, and HbA1c levels, and AGE cellular receptor (RAGE), aldose reductase (AR) and glutamine: fructose-6-phosphate aminotransferase (GFAT) gene expression were assessed in kidney tissue at the end of the experiment. RESULTS: Vitamin D treatment resulted in a significant increase in insulin concentration, which could improve hyperglycaemia in diabetic rats. Serum HbA1c decreased slightly but insignificantly following the vitamin D injections. In addition, expression of GFAT, a key regulatory enzyme in the hexosamine pathway, was significantly reduced following vitamin D administration. CONCLUSION: Vitamin D may reduce diabetic nephropathy not only by improving blood glucose and insulin levels, but also by modulating hexosamine pathways in kidney.
Entities:
Keywords:
Diabetes Mellitus; Hexosamine pathway; Nephropathy; Vitamin D
Authors: Ming Teng; Myles Wolf; M Norma Ofsthun; J Michael Lazarus; Miguel A Hernán; Carlos A Camargo; Ravi Thadhani Journal: J Am Soc Nephrol Date: 2005-02-23 Impact factor: 10.121
Authors: Ravichandran Ramasamy; Susan J Vannucci; Shirley Shi Du Yan; Kevan Herold; Shi Fang Yan; Ann Marie Schmidt Journal: Glycobiology Date: 2005-03-10 Impact factor: 4.313
Authors: Yan Zhang; Dilip K Deb; Juan Kong; Gang Ning; Yurong Wang; George Li; Yunzi Chen; Zhongyi Zhang; Stephen Strugnell; Yves Sabbagh; Cynthia Arbeeny; Yan Chun Li Journal: Am J Physiol Renal Physiol Date: 2009-06-17